High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome
- PMID: 18160439
- PMCID: PMC2258997
- DOI: 10.1128/JVI.02474-07
High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome
Erratum in
- J Virol. 2011 May;85(9):4633
Abstract
We monitored expression of PD-1 (a mediator of T-cell exhaustion and viral persistence) on hepatitis C virus (HCV)-specific CD8(+) and CD4(+) T cells from blood and liver during acute and chronic infections and after the resolved infection stage. PD-1 expression on HCV-specific T cells was high early in acute infection irrespective of clinical outcome, and most cells continued to express PD-1 in resolved and chronic stages of infection; intrahepatic expression levels were especially high. Our results suggest that an analysis of PD-1 expression alone is not sufficient to predict infection outcome or to determine T-cell functionality in HCV infection.
Figures
Similar articles
-
Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction.J Virol. 2007 Sep;81(17):9249-58. doi: 10.1128/JVI.00409-07. Epub 2007 Jun 13. J Virol. 2007. PMID: 17567698 Free PMC article.
-
Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization.Gastroenterology. 2008 Jun;134(7):1927-37, 1937.e1-2. doi: 10.1053/j.gastro.2008.02.033. Epub 2008 Feb 17. Gastroenterology. 2008. PMID: 18549878 Free PMC article.
-
HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression.Eur J Immunol. 2010 Sep;40(9):2493-505. doi: 10.1002/eji.201040340. Eur J Immunol. 2010. PMID: 20623550
-
Virus-Specific Cellular Response in Hepatitis C Virus Infection.Arch Immunol Ther Exp (Warsz). 2016 Apr;64(2):101-10. doi: 10.1007/s00005-015-0364-8. Epub 2015 Oct 1. Arch Immunol Ther Exp (Warsz). 2016. PMID: 26429740 Review.
-
Costimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis C.World J Gastroenterol. 2009 Nov 7;15(41):5129-40. doi: 10.3748/wjg.15.5129. World J Gastroenterol. 2009. PMID: 19891011 Free PMC article. Review.
Cited by
-
Therapeutic DNA vaccination using in vivo electroporation followed by standard of care therapy in patients with genotype 1 chronic hepatitis C.Mol Ther. 2013 Sep;21(9):1796-805. doi: 10.1038/mt.2013.119. Epub 2013 Jun 11. Mol Ther. 2013. PMID: 23752314 Free PMC article. Clinical Trial.
-
Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2-specific T-cells.Eur Respir J. 2022 Jan 13;59(1):2100285. doi: 10.1183/13993003.00285-2021. Print 2022 Jan. Eur Respir J. 2022. PMID: 34140294 Free PMC article.
-
HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory molecules.Sci Rep. 2019 Jul 23;9(1):10624. doi: 10.1038/s41598-019-47024-8. Sci Rep. 2019. PMID: 31337800 Free PMC article.
-
Transcriptional Pattern Analysis of Virus-Specific CD8+ T Cells in Hepatitis C Infection: Increased Expression of TOX and Eomesodermin During and After Persistent Antigen Recognition.Front Immunol. 2022 Jun 6;13:886646. doi: 10.3389/fimmu.2022.886646. eCollection 2022. Front Immunol. 2022. PMID: 35734162 Free PMC article.
-
Immune responses during acute and chronic infection with hepatitis C virus.Clin Immunol. 2008 Aug;128(2):133-47. doi: 10.1016/j.clim.2008.03.525. Epub 2008 Jun 2. Clin Immunol. 2008. PMID: 18514579 Free PMC article. Review.
References
-
- Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439682-687. - PubMed
-
- Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. Depierres, Z. Mncube, J. Duraiswamy, B. Zhu, Q. Eichbaum, M. Altfeld, E. J. Wherry, H. M. Coovadia, P. J. Goulder, P. Klenerman, R. Ahmed, G. J. Freeman, and B. D. Walker. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443350-354. - PubMed
-
- Day, C. L., N. P. Seth, M. Lucas, H. Appel, L. Gauthier, G. M. Lauer, G. K. Robbins, Z. M. Szczepiorkowski, D. R. Casson, R. T. Chung, S. Bell, G. Harcourt, B. D. Walker, P. Klenerman, and K. W. Wucherpfennig. 2003. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J. Clin. Investig. 112831-842. - PMC - PubMed
-
- Kim, A. Y., G. M. Lauer, K. Ouchi, M. M. Addo, M. Lucas, J. Schulze Zur Wiesch, J. Timm, M. Boczanowski, J. E. Duncan, A. G. Wurcel, D. Casson, R. T. Chung, R. Draenert, P. Klenerman, and B. D. Walker. 2005. The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1. Blood 1051170-1178. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials